Heart disease is the leading cause of death for American women. Yet, in the U.S., women are underrepresented in studies of treatments for heart failure, coronary artery disease and similar problems.
Women may respond to medications … Read More »
Malcom Jones, a doctoral student at USC’s Division of Biokinesiology and Physical Therapy, focused on a computer screen as pictures of balls from different sports flashed across it. His fingers flicked back and forth on … Read More »
In an ongoing effort to ensure optimal safety during the developing COVID-19 (novel coronavirus) situation, Keck Medicine of USC and the Keck School of Medicine of USC are implementing a temporary ban on business travel for all international and domestic … Read More »
About a dozen USC students recently spent seven hours of a Saturday absorbing information on college mental health, learning how to recognize distress signs in a peer and memorizing the breadth of USC support resources. The students weren’t there for … Read More »
Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due to neurological conditions — such as a spinal cord injury or … Read More »
If you or someone you love has cancer, Keck Medicine of USC’s Josh Neman, PhD, is in your corner.
The scientist is determined to stop cancerous tumors on the turf he knows best: the lab bench.
An assistant … Read More »
One in six older adults worldwide is believed to be a victim of some form of elder abuse, according to a 2017 World Health Organization (WHO) study. The research defined the mistreatment as falling into several categories: psychological, financial, neglect, … Read More »
In order to offer a central, reliable hub of information regarding the developing COVID-19 (coronavirus) situation, USC has launched usc.edu/coronavirus.
This “living” site includes messages to the USC community, travel information, frequently asked questions and the latest … Read More »
A new interdisciplinary USC study shows that an antidepressant in use for decades, repurposed to fight prostate cancer, could help patients whose disease has returned following surgery or radiation.
The drug — an MAO inhibitor called phenelzine — represents a potential … Read More »